1. Home
  2. TNXP vs WAVE Comparison

TNXP vs WAVE Comparison

Compare TNXP & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • WAVE
  • Stock Information
  • Founded
  • TNXP 2007
  • WAVE 2011
  • Country
  • TNXP United States
  • WAVE Israel
  • Employees
  • TNXP N/A
  • WAVE N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • WAVE Electric Utilities: Central
  • Sector
  • TNXP Health Care
  • WAVE Utilities
  • Exchange
  • TNXP Nasdaq
  • WAVE Nasdaq
  • Market Cap
  • TNXP 15.1M
  • WAVE 13.9M
  • IPO Year
  • TNXP N/A
  • WAVE 2021
  • Fundamental
  • Price
  • TNXP $0.14
  • WAVE $10.45
  • Analyst Decision
  • TNXP Strong Buy
  • WAVE
  • Analyst Count
  • TNXP 2
  • WAVE 0
  • Target Price
  • TNXP $53.50
  • WAVE N/A
  • AVG Volume (30 Days)
  • TNXP 25.0M
  • WAVE 75.8K
  • Earning Date
  • TNXP 11-07-2024
  • WAVE 11-29-2024
  • Dividend Yield
  • TNXP N/A
  • WAVE N/A
  • EPS Growth
  • TNXP N/A
  • WAVE N/A
  • EPS
  • TNXP N/A
  • WAVE N/A
  • Revenue
  • TNXP $12,458,000.00
  • WAVE $306,000.00
  • Revenue This Year
  • TNXP $62.53
  • WAVE N/A
  • Revenue Next Year
  • TNXP $26.17
  • WAVE N/A
  • P/E Ratio
  • TNXP N/A
  • WAVE N/A
  • Revenue Growth
  • TNXP N/A
  • WAVE 1076.92
  • 52 Week Low
  • TNXP $0.12
  • WAVE $1.01
  • 52 Week High
  • TNXP $22.08
  • WAVE $12.39
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 34.48
  • WAVE 84.91
  • Support Level
  • TNXP $0.13
  • WAVE $4.65
  • Resistance Level
  • TNXP $0.18
  • WAVE $5.88
  • Average True Range (ATR)
  • TNXP 0.02
  • WAVE 1.24
  • MACD
  • TNXP 0.01
  • WAVE 0.48
  • Stochastic Oscillator
  • TNXP 23.33
  • WAVE 77.12

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

Share on Social Networks: